12.12.2018 15:50 - About Us - Mediadaten - Imprint & Contact - succidia AG
Scientist > Martina Stützle

Martina Stützle

// studied pharmaceutical biotechnology at Biberach University of Applied Sciences

// She is a doctoral candidate in the Prof. Zimmermann lab in the Institute of Pharma­ceutical Biotechnology at Biberach University of Applied Sciences

// Her thesis topic is the ­“Development of protein aerosols for intranasal nose-to-brain drug delivery”

Contact: laborundmore@succidia.de

How biopharmaceutical drug substances use the nose as a pathway to the brain

Behind the doorman’s back - von Johannes Flamm, Stefan Carle, Martina Stützle, Prof. Dr. Katharina Schindowski Zimmermann

According to WHO estimates, over 1 billion people worldwide suffer from disorders of the central nervous system (CNS). Some of the most familiar are Alzheimer’s, Parkinson’s and multiple sclerosis. Although they have long been the focus of research, effective pharmacotherapies are still unavailable for many of these diseases. What is it about CNS disorders that makes it especially difficult to develop drug products that target pathophysiological...